Description |
1 online resource. |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
Note |
Includes index. |
Reproduction |
Electronic reproduction. Ann Arbor, MI Available via World Wide Web. |
Note |
Online resource; title from PDF title page (SpringerLink, viewed June 26, 2023). |
Contents |
Intro -- Foreword I -- Foreword II -- Preface -- Contents -- Editor and Contributors -- About the Editor -- Contributors -- 1: Hematopoietic Stem Cell Transplantation: An Overview -- Introduction -- Autologous Stem Cell Transplant -- Collection of Stem Cells -- Risk Factors of Poor Mobilization -- Conditioning Regimen -- Allogeneic Stem Cell Transplant -- Donor Selection for Allogeneic HSCT -- Sources of Hematopoietic Stem Cells -- Bone Marrow -- Peripheral Blood -- Umbilical Cord Blood (UCB) -- Conditioning Regimen -- Complications of Stem Cell Transplantation -- Early Complications |
|
Graft-Versus-Host Disease (GVHD) -- Infectious Diseases -- Pre-engraftment: From HSCT to Engraftment (Day 0 to +30) -- Early Post-engraftment: Day +30-100 -- Late Post-engraftment: Beyond Day +100 -- Oral Mucositis -- Hemorrhagic Cystitis -- Sinusoidal Obstruction Syndrome (SOS) -- Transplant-Associated Microangiopathy (TMA) -- Late Complications -- References -- 2: An Overview of Graft-Versus-Host Disease -- Introduction -- Pathophysiology of GVHD -- GVHD: Incidence and Impact on Non-relapse Mortality (NRM) -- Risk Factors of GVHD -- Classification of GVHD -- Staging and Grading of Acute GVHD |
|
Staging/Grading of Chronic GVHD -- Introduction of the Concept of GVHD Prophylaxis -- Introduction of Cyclosporine A for GVHD Prophylaxis -- Use of Combination Drugs for GVHD Prophylaxis -- Trials Assessing Tacrolimus Versus CsA -- Mycophenolate Mofetil (MMF) -- Antithymocyte Globulin (ATG) for In Vivo T-Cell Depletion -- Posttransplantation Cyclophosphamide (PTCy) -- Sirolimus -- Ex Vivo T-Cell Depletion for GVHD Prophylaxis -- Targeting T-Cell Co-stimulatory Receptors -- Treatment of GVHD -- Pulmonary Perspectives -- References |
|
3: Pulmonary Complications Following Hematopoietic Stem Cell Transplantation: Spectrum, Incidence, Risk Factors, and Outcomes -- Introduction -- Infectious Complications -- Bacterial Complications -- Pneumonia -- Nocardia -- Mycobacterium tuberculosis (MTB) -- Nontuberculous Mycobacterial Infections -- Viral Complications -- Cytomegalovirus -- Respiratory Virus Infections (RVI) -- SARS-CoV-2 -- Invasive Fungal Infections -- Noninfectious Complications -- Idiopathic Pneumonia Syndrome (IPS) -- Peri-Engraftment Respiratory Distress Syndrome (PERDS) -- Diffuse Alveolar Hemorrhage (DAH) |
|
Cryptogenic Organizing Pneumonia (COP) -- Bronchiolitis Obliterans Syndrome (BOS) -- Interstitial Lung Disease (ILD) -- Pulmonary Hypertension and Pulmonary Veno-Occlusive Disease (PVOD) -- Thoracic Air Leak Syndrome (TALS) -- Pleural Effusions -- Venous Thromboembolic Disease (VTE) and Pulmonary Cytolytic Thrombi (PCT) -- Other Noninfectious Complications -- Acute Respiratory Failure and Mechanical Ventilation -- Diagnostic Considerations of Noninfectious Pulmonary Complications Following HSCT -- Conclusion -- References -- 4: Pretransplant Pulmonary Evaluation -- Introduction |
Subject |
Hematopoietic stem cells -- Transplantation.
|
|
Hematopoietic stem cell disorders -- Treatment.
|
|
Critical care medicine.
|
|
Lungs -- Diseases.
|
Added Author |
Soubani, Ayman O., editor.
|
|
ProQuest (Firm)
|
Related To |
Original 3031287967 9783031287961 |
ISBN |
9783031287978 (electronic bk.) |
|
3031287975 (electronic bk.) |
|
9783031287961 |
|
3031287967 |
UPC # |
10.1007/978-3-031-28797-8 doi |
OCLC # |
EBC30594660 |
|